Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric S Kilpatrick

Showing results (21-30 of 124) with videos related to

Pageof 13
Sort By:
Annals of Clinical Biochemistry|September 3, 2011
A national audit of estimated glomerular filtration rate and proteinuria reporting in the UKEric S Kilpatrick, Helen Verrill,
BMJ (Clinical Research Ed.)|April 29, 2014
Using haemoglobin A(1c) to diagnose type 2 diabetes or to identify people at high risk of diabetesEric S Kilpatrick, Stephen L Atkin
Annals of Clinical Biochemistry|November 25, 2003
Tumour markers: their use and misuse by cliniciansPeter J McGinley, Eric S Kilpatrick
Annals of Clinical Biochemistry|May 18, 2006
Whither clinical validation?Eric S Kilpatrick, Julian H Barth
Diabetes Care|November 23, 2013
Comment on: Selvin et al. No racial differences in the association of glycated hemoglobin with kidney disease and cardiovascular outcomes. Diabetes Care 2013;36:2995-3001Eric S Kilpatrick, Zachary T Bloomgarden
BMJ (Clinical Research Ed.)|September 24, 2009
Appropriate requesting of serum tumour markersEric S Kilpatrick, Michael J Lind
Annals of Clinical Biochemistry|June 15, 2011
A national survey of interpretative reporting in the UKEric S Kilpatrick, Danielle B Freedman,
Nephron. Clinical Practice|August 13, 2009
Is there still a role for measuring serum urea in an age of eGFR? Evidence of its use when assessing patient hydrationJohn Shepherd, Steve Hatfield, Eric S Kilpatrick
Diabetes Care|December 31, 2008
Translating the A1C assay into estimated average glucose values: response to Nathan et alR David G Leslie, Eric S Kilpatrick
Diabetes Care|September 1, 2010
Disparate effects of atorvastatin compared with simvastatin on C-reactive protein concentrations in patients with type 2 diabetesThozhukat Sathyapalan, Stephen L Atkin, Eric S Kilpatrick
Pageof 13

Showing results (21-30 of 124) with videos related to

Sort By:
Pageof 13
Annals of Clinical Biochemistry|September 3, 2011
A national audit of estimated glomerular filtration rate and proteinuria reporting in the UKEric S Kilpatrick, Helen Verrill,
BMJ (Clinical Research Ed.)|April 29, 2014
Using haemoglobin A(1c) to diagnose type 2 diabetes or to identify people at high risk of diabetesEric S Kilpatrick, Stephen L Atkin
Annals of Clinical Biochemistry|November 25, 2003
Tumour markers: their use and misuse by cliniciansPeter J McGinley, Eric S Kilpatrick
Annals of Clinical Biochemistry|May 18, 2006
Whither clinical validation?Eric S Kilpatrick, Julian H Barth
Diabetes Care|November 23, 2013
Comment on: Selvin et al. No racial differences in the association of glycated hemoglobin with kidney disease and cardiovascular outcomes. Diabetes Care 2013;36:2995-3001Eric S Kilpatrick, Zachary T Bloomgarden
BMJ (Clinical Research Ed.)|September 24, 2009
Appropriate requesting of serum tumour markersEric S Kilpatrick, Michael J Lind
Annals of Clinical Biochemistry|June 15, 2011
A national survey of interpretative reporting in the UKEric S Kilpatrick, Danielle B Freedman,
Nephron. Clinical Practice|August 13, 2009
Is there still a role for measuring serum urea in an age of eGFR? Evidence of its use when assessing patient hydrationJohn Shepherd, Steve Hatfield, Eric S Kilpatrick
Diabetes Care|December 31, 2008
Translating the A1C assay into estimated average glucose values: response to Nathan et alR David G Leslie, Eric S Kilpatrick
Diabetes Care|September 1, 2010
Disparate effects of atorvastatin compared with simvastatin on C-reactive protein concentrations in patients with type 2 diabetesThozhukat Sathyapalan, Stephen L Atkin, Eric S Kilpatrick
Pageof 13